Heart rate reserve during pharmacological stress is a significant negative predictor of impaired coronary flow reserve in women.
Aged
Area Under Curve
Coronary Artery Disease
/ diagnostic imaging
Coronary Circulation
Exercise Test
Female
Fractional Flow Reserve, Myocardial
Heart Rate
Hemodynamics
Humans
Image Processing, Computer-Assisted
Male
Middle Aged
Multivariate Analysis
Myocardial Ischemia
/ physiopathology
Myocardial Perfusion Imaging
Nitrogen Isotopes
Nitrogen Radioisotopes
Positron-Emission Tomography
ROC Curve
Radiopharmaceuticals
Risk
Risk Factors
Sensitivity and Specificity
Sex Factors
13N-ammonia PET
Adenosine
Coronary artery disease
Heart rate reserve
Women
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
14
09
2018
accepted:
04
01
2019
pubmed:
17
1
2019
medline:
21
7
2020
entrez:
17
1
2019
Statut:
ppublish
Résumé
Evidence to date has failed to adequately explore determinants of cardiovascular risk in women with coronary microvascular dysfunction (CMVD). Heart rate responses to adenosine mirror autonomic activity and may carry important prognostic information for the diagnosis of CMVD. Hemodynamic changes during adenosine stress were analyzed in a propensity-matched cohort of 404 patients (202 women, mean age 65.9 ± 11.0) who underwent clinically indicated myocardial perfusion Baseline heart rate (HR) was significantly higher in patients with abnormal coronary flow reserve (CFR, p < 0.001 vs normal CFR). Accordingly, a blunted HR response to adenosine (=reduced heart rate reserve, %HRR) was seen in patients with abnormal CFR, with a most pronounced effect being observed in female patients free of myocardial ischemia (45.9 ± 34.9 vs 26.5 ± 18.0, p < 0.001 in women and 29.1 ± 16.9 vs 24.3 ± 21.7, p = 0.15 in men). Hence, a fully-adjusted multivariate logistic regression model identified HRR as the strongest negative predictor of reduced CFR in women free of myocardial ischemia, but not in men. Accordingly, receiver operating characteristics (ROC) curves for the presence of reduced CFR revealed that a %HRR <35 was a powerful predictor for abnormal CFR with a sensitivity of 81% and a specificity of 60% in women. A blunted HRR <35% is associated with abnormal CFR in women. Taking into account HR responses during stress test in women may help to risk stratify the heterogeneous female population of patients with non-obstructive coronary artery disease (CAD).
Identifiants
pubmed: 30648200
doi: 10.1007/s00259-019-4265-7
pii: 10.1007/s00259-019-4265-7
doi:
Substances chimiques
Nitrogen Isotopes
0
Nitrogen Radioisotopes
0
Radiopharmaceuticals
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1257-1267Subventions
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CH)
ID : Research grant to CG
Organisme : Olga Mayenfisch Foundation
ID : Research grant to CG
Organisme : OPO-Stiftung
ID : Research grant to CG
Organisme : Novartis Stiftung für Medizinisch-Biologische Forschung
ID : Research grant to CG
Organisme : Swissheart Foundation
ID : Research grant to CG
Organisme : Helmut Horten Foundation
ID : Research grant to CG
Organisme : Iten-Kohaut Foundation
ID : Research grant to MM
Références
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9226-33
pubmed: 10922074
Cardiovasc Res. 2001 Apr;50(1):151-61
pubmed: 11282088
Cardiovasc Res. 2001 Nov;52(2):208-16
pubmed: 11684068
Am J Cardiol. 2002 Jan 15;89(2):174-7
pubmed: 11792338
Circulation. 2003 Jun 17;107(23):2894-9
pubmed: 12796141
Circulation. 2005 Feb 8;111(5):682-96
pubmed: 15687114
Heart. 2006 May;92 Suppl 3:iii5-9
pubmed: 16614266
Am J Cardiol. 1991 Dec 15;68(17):1698-703
pubmed: 1746475
Acad Radiol. 2008 Apr;15(4):444-51
pubmed: 18342769
Am J Cardiol. 2008 Oct 15;102(8):1103-6
pubmed: 18929717
Am Heart J. 2009 Apr;157(4):771-6
pubmed: 19332209
Circulation. 2009 Jun 9;119(22):e561-87
pubmed: 19451357
J Am Coll Cardiol. 2009 Jul 7;54(2):150-6
pubmed: 19573732
Am J Cardiol. 2010 Mar 15;105(6):839-43
pubmed: 20211328
J Am Coll Cardiol. 1991 Jun;17(7):1461-70
pubmed: 2033177
J Nucl Med. 2010 Jul;51(7):1036-43
pubmed: 20554740
J Am Coll Cardiol. 2010 Jun 22;55(25):2825-32
pubmed: 20579539
J Nucl Cardiol. 2011 Dec;18(6):1086-94
pubmed: 21785922
Circulation. 2011 Nov 15;124(20):2215-24
pubmed: 22007073
Int J Cardiol. 2013 Aug 10;167(3):1023-6
pubmed: 22475847
J Am Coll Cardiol. 2012 May 8;59(19):1719-28
pubmed: 22554604
Imaging Med. 2013 Feb 1;5(1):35-46
pubmed: 23671459
J Nucl Med. 2013 Aug;54(8):1485-507
pubmed: 23781013
Am Heart J. 2013 Jul;166(1):38-44
pubmed: 23816019
Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):659-65
pubmed: 24408930
Circulation. 2014 Jun 17;129(24):2518-27
pubmed: 24787469
Int J Cardiovasc Imaging. 2015 Jun;31(5):1089-95
pubmed: 25846547
Nat Rev Cardiol. 2015 Jul;12(7):406-14
pubmed: 26011377
Circulation. 2015 Sep 15;132(11):997-1002
pubmed: 26302759
J Am Coll Cardiol. 2015 Oct 27;66(17):1918-33
pubmed: 26493665
Heart Fail Clin. 2016 Jan;12(1):141-56
pubmed: 26567981
Circulation. 1989 Jul;80(1):87-98
pubmed: 2661056
JACC Cardiovasc Imaging. 2016 Apr;9(4):421-35
pubmed: 27056162
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
J Nucl Cardiol. 2018 Apr 23;:null
pubmed: 29687292
Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1964-1974
pubmed: 29779046
PLoS One. 2018 Aug 14;13(8):e0202302
pubmed: 30106984
Acta Physiol Scand. 1987 Dec;131(4):525-31
pubmed: 3327362
Radiology. 1988 Sep;168(3):878-9
pubmed: 3406418
J Am Coll Cardiol. 1993 Nov 15;22(6):1607-13
pubmed: 8227827
J Am Coll Cardiol. 1996 Nov 1;28(5):1214-9
pubmed: 8890818
Am J Cardiol. 1997 Jul 15;80(2):132-7
pubmed: 9230147
Am J Cardiol. 1998 Sep 15;82(6):725-30
pubmed: 9761081